OBI Pharma, Inc. (TPEX:4174)

OBI Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,744	15,388	15,910	15,831	22,680	26,213
Market Cap Growth	6.84%	-3.28%	0.50%	-30.20%	-13.48%	5.56%
Enterprise Value	7,769	15,559	14,396	12,411	21,039	22,895
Last Close Price	33.25	58.50	68.99	68.69	112.19	136.79
PS Ratio	128.58	245.51	382.92	3360.52	1208.19	186.06
PB Ratio	2.04	3.19	3.21	2.58	5.86	5.42
P/TBV Ratio	2.69	4.10	4.26	3.73	9.79	6.94
EV/Sales Ratio	114.24	248.24	346.49	2634.54	1120.77	162.51
Debt / Equity Ratio	0.12	0.11	0.11	0.05	0.08	0.05
Asset Turnover	0.01	0.01	0.01	0.00	0.00	0.02
Inventory Turnover	4.86	5.18	4.80	2.85	5.24	1.12
Quick Ratio	11.32	7.65	17.00	21.71	8.18	15.05
Current Ratio	12.64	8.34	19.10	22.76	8.72	15.67
Return on Equity (ROE)	-57.04%	-51.01%	-22.83%	-37.96%	-39.45%	-27.69%
Return on Assets (ROA)	-29.11%	-26.32%	-21.33%	-23.86%	-21.83%	-15.49%
Return on Capital (ROIC)	-29.67%	-27.38%	-21.90%	-25.05%	-23.20%	-16.24%
Earnings Yield	-26.30%	-15.01%	-6.58%	-10.19%	-6.75%	-5.26%
FCF Yield	-23.58%	-12.65%	-11.03%	-11.84%	-5.76%	-6.84%
Buyback Yield / Dilution	-5.63%	-1.99%	-3.12%	-11.65%	-0.18%	-3.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.